期刊文献+

胃癌肝高转移细胞结合肽的特异性鉴定 被引量:4

Identification of phage displayed peptides specifically binding to high liver-metastatic gastric cancer cells
下载PDF
导出
摘要 目的 鉴定选择性噬菌体阳性克隆是否可与胃癌肝高转移细胞—XGC9811 -L特异性结合。方法 利用竞争结合试验检测噬菌体阳性克隆与XGC9811-L细胞的结合效率。竞争抑制实验确定阳性噬菌体与靶细胞的结合性是否通过外源呈现肽发挥作用。细胞结合ELI-lSA实验和免疫荧光技术鉴定phage20与靶细胞XGC9811-L结合的特异性。结果 在8个阳性克隆中,phage20与XGC9811 -L细胞的结合效率最高,达100%,是原噬菌体肽库的50倍,随着外源呈现肽浓度的增加,phage20与靶细胞的结合力随之减弱。phage20可与XGC9811 -L特异结合,并可内化入细胞。结论 在8个噬菌体阳性克隆中,phage20与XGC9811-L细胞具有高度结合力,并呈现出明显的细胞特异性。 Objective To identify whether eight candidate phages c ould specifically bind to the high liver-metastatic gastric cancer cells (XGC-9 811-L). Methods Competitive binding assays were performe d to test the binding efficiency of the selected candidate phages to XGC9811-L. The competitive inhibition test was carried out to determine if phage binding wa s mediated through the displayed peptides. Immunofluorescent technique and ELISA were used to test the cell-specificity of selected peptides. Results Among 8 candidate phages, phage20 had the highest binding efficienc y to XGC9811-L, which showed 50-fold stronger than the original library. With th e concentra-tion of the peptides increased the binding efficiency of phage20 to XGC9811-L decreased accordingly. The specificity binding assays d emonstrated phage20 could bind to XGC9811-L specifically, furthermore, it could be internalized into the target cells. Conclusion Among t he 8 candidate phages, pahge20 had the highest binding efficiency and showed an obviously cell-specificity.
出处 《现代肿瘤医学》 CAS 2005年第2期158-160,共3页 Journal of Modern Oncology
基金 国家自然科学基金资助项目(项目编号: 30160033)
关键词 胃癌 肝转移 噬菌体呈现肽 特异性 gastric cancer liver metastasis phage disflayed fept ide specifrcity
  • 相关文献

参考文献10

  • 1Miyazaki M, Itoh H, Nakagawa K, et al. Hepatation resection of liver metastases from gastric carcinoma [J]. Am J Gastroenterol,1997,92 (3):490~493.
  • 2Hiroyuki Konno. Antitumor effect of the angiogenesis inhibitor TNP -470 on human digestive organ malignancy[J]. Cancer Chemother Pharmacol, 1999,43 (suppl): S85 ~ S89.
  • 3Yoshio G, Serdar Y, Takao S, et al. Analysis of Experimental Liver Metastasis from Tumors Inoculation the Mouse Stomach Cavity[J]. Surg Today,2002,32:142 ~ 147.
  • 4Jennifer couzin. Tracing the Steps of Metastasis Cancer's Menacing Ballet [J]. Science,2003,299:1002 ~ 1005.
  • 5Poul MA, Becerril B, Nielsen UB, et al. Selection of tumor specific internalizing human antibodies from phage libraries [J]. J Mol Biol,2000,301:1149 ~ 1161.
  • 6Arap W, Pasqualini R. , Ruoslahti E. et al. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model [J].Science, 1998,297 (5349): 377 ~ 380.
  • 7Ellery HM, Arap W, et al. Anti - cancer activity of targeted proapoptotic peptides[J]. Nat Med, 1999,5(9) :1032 - 1038.
  • 8Tsuksa O, Kathryn F, Kausar N, Samlia, b, John D. et al Isolation of lung tumor specific peptides from a random pcptide library:generation of diagnostic and cell - targeting reagents [J]. Cancer letters ,2003,202:219 ~ 230.
  • 9Hertner T, Moor A, Garrison J. L. , Marks C, et al. Selection of cell binding and internalizing epidermal growth factor receptor antibodies from a phage display library[J]. J Immunol Methods,2001,248(1 -2) :17 -30.
  • 10Hood JD, Bednarski M, Frausto R, et al. Tumor regression by targeted gene delivery to the neovasculature [J]. Science, 2002,296:2404 ~ 2407.

同被引文献29

  • 1[1]Hiroyuki Konno.Antitumor effect of the angiogenesis inhibitor TNP -470 on human digestive organmalignancy[J].Cancer Chemother Pharmacol,1999,43:S85-S89.
  • 2[2]Yoshio G,Serdar Y,Takao S,et al.Analysis of experimental lver metastasis from tumors inaculatedin the mouse stomach cavity[J].Surg Today,2002,32:142-147.
  • 3[3]Paget S.The distribution of secondary growths in cancer of the breast[J].Lancet,1989,1:571.
  • 4[4]Jennifer couzin.Tracing the steps of metastasis cancer's menacing ballet[J].Science,2003,1:299.
  • 5[5]Shengjuan Hu,Xinning Guo,Daiming Fan,et al.Phage display selection of peptides that inhibit metastasis abihty of gastric cancer cells with high liver-metastatic potential[J].Biochem Biophys Res Commun,2006,341(4):964-972.
  • 6[7]Otte JM,Schmitz F,Kiehne K,et al.Functional expression of HGF and its receptor in human coiorectal cancer[J].Digestion,2000,61(4):237-246.
  • 7[8]Yonemura Y,Ninomiya I,Kaji M,et al.Decreased E-cadherin expression in correlation with poor survival on patients with gastric cancer[J].Anal Cell Pathol,1995,8:177-190.
  • 8[9]Berns A,Boyle P,Canneliet P,et al.Adaptable integring[J].Nature Bey,2002,2:3.
  • 9[10]Yamaguchi K,Ura H,Yasashima T,et al.Liver metastatic model for human gastric cancer established by orthotopic tumor cell implantation[J].Wodd J Surg,2001,25(2):131-137.
  • 10[11]Perera FP.Environment and cancer;Who ale susceptible[J]?Science,1997,278:1068-1073.

引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部